Abstract
Background:
A death rattle, characterized by noisy breathing due to accumulated secretions, is a common symptom in terminally ill patients with cancer; however, its predictive factors have yet to be fully elucidated.
Objectives:
This study aimed to identify predictors for developing a death rattle in patients with advanced cancer.
Design:
This is a secondary analysis of a multicenter prospective cohort study.
Setting/Subjects:
We enrolled 1633 patients with advanced cancer admitted to 23 palliative care units throughout Japan.
Measurements:
We examined associations between patient characteristics, comorbidities, and treatments and the development of a death rattle (Back score ≥2) when Palliative Performance Scale scores dropped to 20 or less using logistic regression analysis.
Results:
A death rattle developed in 196 patients (12.0%). Multivariate analysis revealed that smoking history, cerebrovascular disease/congestive heart failure history, lung metastasis, moderate-to-severe edema on admission, symptomatic pleural effusion, high-dose antipsychotics, and hydration volume ≥200 mL/day when the performance status score was ≤20 was significantly associated with death rattle development. Moderate-to-severe edema and high-dose antipsychotics were predictors for a type 1 rattle (predominantly pharyngeal secretions), whereas smoking history was a predictor for a type 2 rattle (predominantly bronchial secretions).
Conclusions:
Volume overload, dysphagia, and factors related to sputum production were identified as predictors for death rattle development in terminally ill patients with cancer.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
